Serum dihomo-g-linolenic acid concentration
as a potential novel noninvasive biomarker
for liver steatosis detection in children

Serum dihomo-g-linolenic acid concentration as a potential novel noninvasive biomarker for liver steatosis detection in children

Saved in:

Bibliographic Details
Main Authors:	Natalia Kopiczko, Anna Bobrus-Chociej, Ewa Harasim-Symbor, Marta Flisiak-Jackiewicz, Monika Kowalczuk-Krystoń, Eugeniusz Tarasów, Adrian Chabowski, Dariusz Lebensztejn
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-12-01
Series:	Clinical & Experimental Hepatology
Subjects:	obesity children masld metabolic dysfunction-associated steatotic liver disease dihomo-g-linolenic acid
Online Access:	https://www.termedia.pl/Serum-dihomo-g-linolenic-acid-concentration-r-nas-a-potential-novel-noninvasive-biomarker-r-nfor-liver-steatosis-detection-in-children,80,55213,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exogenous dihomo-γ-linolenic acid triggers ferroptosis via ACSL4-mediated lipid metabolic reprogramming in acute myeloid leukemia cells
by: Xiandong Jiang, et al.
Published: (2025-02-01)

Uric acid as a potential marker of cardiometabolic risk in children and adolescents with metabolic dysfunction associated steatotic liver disease
by: Katarzyna Zdanowicz, et al.
Published: (2024-09-01)

Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children
by: Marta Flisiak-Jackiewicz, et al.
Published: (2018-01-01)

γ-亚麻酸对α-亚麻酸转化为DHA的影响 Effect of γ-linolenic acid on the conversion of α-linolenic acid to DHA
by: 谢婉菲1，姜珊1，王成成1，王玉明1,2，薛长湖1,2，张恬恬1 " XIE Wanfei1, JIANG Shan1, WANG Chengcheng1, WANG Yuming1,2, XUE Changhu1,2, ZHANG Tiantian1"
Published: (2025-01-01)

Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial
by: Sakkarin Chirapongsathorn, et al.
Published: (2025-01-01)

Transcriptome analysis reveals the molecular mechanism of γ-linolenic acid eradicating the biofilm of vancomycin-resistant Enterococcus faecium
by: Ming Wei, et al.
Published: (2025-01-01)

Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017–2020
by: Xin Qiu, et al.
Published: (2025-01-01)

The associations between diet-induced inflammation and the improvement or worsening of hepatic steatosis and fibrosis: a longitudinal analysis of RaNCD cohort study
by: Mohammad Sedighi, et al.
Published: (2025-01-01)

The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease
by: James P. Hardwick, et al.
Published: (2025-01-01)

Augmenter of Liver Regeneration Crotonylation Assists in Mitochondria-ER Contact to Alleviate Hepatic SteatosisSummary
by: Xiao-lin Wang, et al.
Published: (2025-01-01)

Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated steatotic liver disease by regulating lipid metabolism and oxidative stress
by: Ju Zhou, et al.
Published: (2025-01-01)

Treatment of HCV infection in patients with steatotic liver disease
by: Robert Flisiak, et al.
Published: (2024-07-01)

Ferroptosis as a potential connection between schizophrenia and metabolic dysfunction-associated steatotic liver disease – a narrative review
by: Jakub Rogalski, et al.
Published: (2024-09-01)

Chemical Characterization and Differential Lipid-Modulating Effects of Selected Plant Extracts from Côa Valley (Portugal) in a Cell Model for Liver Steatosis
by: Ricardo Amorim, et al.
Published: (2025-01-01)

HEMPSEED AND COTTONSEED OILS IN THE ACCESSIONS FROM THE VIR COLLECTION AS SOURCES OF FUNCTIONAL FOOD INGREDIENTS
by: S. V. Grigoryev, et al.
Published: (2019-10-01)

Hepatokine leukocyte cell‐derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction‐associated steatotic liver disease in the general population
by: Keita Suzuki, et al.
Published: (2025-02-01)

Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice
by: Rumeng Ren, et al.
Published: (2025-01-01)

Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
by: Antonio Liguori, et al.
Published: (2025-01-01)

A narrative review about cognitive impairment in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approach
by: Marica Meroni, et al.
Published: (2025-02-01)

Essential fatty acids as major lipid fraction in Nostoc muscorum by optimization of mixotrophic culture
by: María Guadalupe Mata-Pérez, et al.
Published: (2025-01-01)

Effects of celastrol on the heart and liver galaninergic system expression in a mouse model of Western-type diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis
by: Nikolina Canová, et al.
Published: (2025-02-01)

Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes
by: Yiheng Zhang, et al.
Published: (2025-02-01)

Intrahepatic levels of microbiome-derived hippurate associates with improved metabolic dysfunction-associated steatotic liver disease
by: Maxime Deslande, et al.
Published: (2025-02-01)

Efficacy of fish oil supplementation on metabolic dysfunction-associated steatotic liver disease: a meta-analysis
by: Like Zhou, et al.
Published: (2025-01-01)

Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Vittoria Cammisotto, et al.
Published: (2025-01-01)

Association between cardiovascular health and metabolic dysfunction-associated steatotic liver disease: a nationwide cross-sectional study
by: Lian-Zhen Huang, et al.
Published: (2025-01-01)

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01)

BMI gain and dietary characteristics are risk factors of MASLD in non-obese individuals
by: Hirokazu Taniguchi, et al.
Published: (2025-01-01)

Identification of retinol dehydrogenase 10 as a shared biomarker for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus
by: Fangyu Li, et al.
Published: (2025-01-01)

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)

Comparative Analysis of γ-Cyclodextrin, Perilla Oil, and Their Inclusion Complexes on Liver Injury and Dyslipidemia Associated with Elevated Gastrointestinal 12-Hydroxylated Bile Acid Levels
by: Keisuke Yoshikiyo, et al.
Published: (2025-01-01)

Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Paweł Rajewski, et al.
Published: (2025-01-01)

Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
by: Núria Granel, et al.
Published: (2025-02-01)

A comprehensive analysis of percutaneous liver biopsy characteristics and pathological manifestations in a large patient cohort (2009–2024)
by: Minling Cao, et al.
Published: (2025-02-01)

The Effects of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: A Post Hoc Analysis of the Sapporo-Oral SEMA Study
by: Hiroya Kitsunai, et al.
Published: (2025-01-01)

Superior liver protection in mice fed total parenteral nutrition containing the novel lipid emulsion Vegaven as compared to a mixed-oil lipid emulsion containing fish oil
by: Eliana Lucchinetti, et al.
Published: (2025-04-01)

Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway
by: Shenghe Deng, et al.
Published: (2025-12-01)

Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank
by: Yanan Qiao, et al.
Published: (2025-01-01)

Altered mitochondrial unfolded protein response and FGF21 secretion in MASLD progression and the effect of exercise intervention
by: Xinmeng Yuan, et al.
Published: (2025-01-01)

Alpha-linolenic acid-mediated epigenetic reprogramming of cervical cancer cell lines
by: Amrita Ulhe, et al.
Published: (2025-12-01)